ATE243696T1 - C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren - Google Patents

C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren

Info

Publication number
ATE243696T1
ATE243696T1 AT99936602T AT99936602T ATE243696T1 AT E243696 T1 ATE243696 T1 AT E243696T1 AT 99936602 T AT99936602 T AT 99936602T AT 99936602 T AT99936602 T AT 99936602T AT E243696 T1 ATE243696 T1 AT E243696T1
Authority
AT
Austria
Prior art keywords
inhibitors
derivatives
formaldehydacetal
lactamas
carbapenem
Prior art date
Application number
AT99936602T
Other languages
German (de)
English (en)
Inventor
Hans Rudolf Prof Pfaendler
Original Assignee
Hans Rudolf Prof Pfaendler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Rudolf Prof Pfaendler filed Critical Hans Rudolf Prof Pfaendler
Application granted granted Critical
Publication of ATE243696T1 publication Critical patent/ATE243696T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT99936602T 1998-07-28 1999-07-23 C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren ATE243696T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98114067A EP0976752A1 (en) 1998-07-28 1998-07-28 C-2 S/O- and S/N-Formaldehyde acetal derivatives of carbapenem antibiotics
PCT/EP1999/005295 WO2000006574A1 (en) 1998-07-28 1999-07-23 NOVEL C-2 S/O- AND S/N FORMALDEHYDE ACETAL DERIVATIVES OF CARBAPENEM-3-CARBOXYLIC ACIDS AND THEIR USE AS ANTIBIOTICS AND β-LACTAMASE INHIBITORS

Publications (1)

Publication Number Publication Date
ATE243696T1 true ATE243696T1 (de) 2003-07-15

Family

ID=8232355

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936602T ATE243696T1 (de) 1998-07-28 1999-07-23 C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren

Country Status (17)

Country Link
US (1) US6482818B2 (enExample)
EP (2) EP0976752A1 (enExample)
JP (1) JP4598273B2 (enExample)
KR (1) KR20010086351A (enExample)
CN (1) CN1154649C (enExample)
AT (1) ATE243696T1 (enExample)
AU (1) AU760249B2 (enExample)
CA (1) CA2338776C (enExample)
DE (1) DE69909098T2 (enExample)
ES (1) ES2203164T3 (enExample)
HU (1) HUP0102729A3 (enExample)
IL (1) IL141114A (enExample)
MX (1) MXPA01000905A (enExample)
NZ (1) NZ509578A (enExample)
PT (1) PT1100800E (enExample)
WO (1) WO2000006574A1 (enExample)
ZA (1) ZA200100737B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE464280T1 (de) * 2004-08-23 2010-04-15 Sicor Inc Synthese von idarubin-aglycon
AU2008253257B2 (en) 2007-05-21 2013-10-03 Hans Rudolf Pfaendler Bactericidal anti-MRSA active pharmaceutical composition containing carbapenems
CN101412718B (zh) * 2007-10-19 2011-04-27 山东轩竹医药科技有限公司 含有硫基杂环胺甲酰基的碳青霉烯衍生物
CN103059028B (zh) * 2013-01-30 2014-05-07 山东罗欣药业股份有限公司 一种替比培南匹伏酯的制备方法
CN114957258A (zh) * 2021-02-25 2022-08-30 华东理工大学 基于碳青霉烯结构的广谱丝氨酸β-内酰胺酶抑制剂的合成及其在耐药细菌抑制中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58116485A (ja) * 1981-12-29 1983-07-11 Shionogi & Co Ltd 新規抗生物質カルバペネム誘導体およびその製造法
JPS58124785A (ja) * 1982-01-20 1983-07-25 Shionogi & Co Ltd プルラシドマイシンbおよびcのデオキシ体ならびにその製造法
EP0079244B1 (en) * 1981-11-10 1986-12-30 Shionogi & Co., Ltd. Pluracidomycin b,c, and d and analogs thereof, their production and a microorganism for use therein
JPS6054387A (ja) * 1983-08-03 1985-03-28 メルク エンド カムパニ− インコ−ポレ−テツド チエナマイシンの誘導体製造法
CA1285940C (en) * 1984-07-02 1991-07-09 Merck & Co., Inc. Carbapenems having a 2-quaternary heteroarylalkylthio substituent
IE851586L (en) * 1984-07-02 1986-01-02 Interchem Internat S A I methylcarbapenems having a 2-quaternary¹heteroarylalkylthio substituent
JPS63255283A (ja) * 1987-04-11 1988-10-21 Nippon Redarii Kk (1r,5s,6s)−2−〔(3−置換イミダゾリニウム−1−イル)アルキル〕チオ−6−〔(r)−1−ヒドロキシエチル〕−1−メチル−カルバペネム−3−カルボキシレ−ト
US5116833A (en) * 1990-10-19 1992-05-26 Bristol-Myers Squibb Company Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof

Also Published As

Publication number Publication date
DE69909098T2 (de) 2004-04-08
US6482818B2 (en) 2002-11-19
HUP0102729A2 (hu) 2002-01-28
MXPA01000905A (es) 2002-06-04
JP4598273B2 (ja) 2010-12-15
EP1100800B1 (en) 2003-06-25
EP1100800A1 (en) 2001-05-23
NZ509578A (en) 2003-06-30
CA2338776C (en) 2008-04-29
CN1154649C (zh) 2004-06-23
HUP0102729A3 (en) 2002-09-30
DE69909098D1 (de) 2003-07-31
IL141114A (en) 2004-02-08
CA2338776A1 (en) 2000-02-10
WO2000006574A1 (en) 2000-02-10
AU760249B2 (en) 2003-05-08
US20010031749A1 (en) 2001-10-18
JP2002521484A (ja) 2002-07-16
ES2203164T3 (es) 2004-04-01
IL141114A0 (en) 2002-02-10
AU5163999A (en) 2000-02-21
CN1311790A (zh) 2001-09-05
EP0976752A1 (en) 2000-02-02
KR20010086351A (ko) 2001-09-10
ZA200100737B (en) 2002-07-25
PT1100800E (pt) 2003-11-28

Similar Documents

Publication Publication Date Title
DE60315265D1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
PT747374E (pt) Benzopiranos substituidos com sulfonamido activadores dos canais do potassio
DK0771794T3 (da) Oxygenholdige heterocykliske forbindelser
DE69906940D1 (de) Bizyclische pyrrolverbindungen, deren pharmazeutische zusammensetzungen und ihre verwendung als entzündungshemmende und immunmodulierende mittel
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
ATE140003T1 (de) 1,8-naphthyridin-2-on-derivate
EP1008592A3 (en) Cyclic amide derivatives which inhibit cathepsin K
ATE252074T1 (de) Phenylalkylcarbonsäure-derivate
FI98215B (fi) Menetelmä dihydropyridiinijohdannaisten valmistamiseksi, jotka ovat käyttökelpoisia kasvainten vastaisessa terapiassa
ATE243696T1 (de) C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren
KR870003992A (ko) 락탐 유도체, 그의 제조법 및 혈압강하제로의 이용
NO921159L (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
DE69201184D1 (de) 5- Piperazinylalkyl-1,5-Benzothiazepinone verwendbar als Calciumantagonisten.
ATE375343T1 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
ATE151750T1 (de) 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
ATE222583T1 (de) Derivate substituierter amidinonaphthylester
ATE258934T1 (de) Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
EP0779277A4 (en) 1,4-DIHYDROPYRIDINE DERIVATIVES
DE69427100D1 (de) Herstellung von Beta-lactamverbindungen und Zwischenprodukte
EP1020440A4 (en) FOR THE PRODUCTION OF CARBAPENEM USEFUL INTERMEDIATE PRODUCTS AND METHOD FOR THEIR STEREOSELECTIVE SYNTHESIS
ES2188464T3 (es) Procedimiento para la obtencion de esteres de n-acil-aminoacidos y n-acil-aminoacetales.
ATE148885T1 (de) Imidazopyridin-derivate und verfahren zu ihrer herstellung
DE69707793D1 (de) Alkynylaminosäure Derivate und ihre Verwendung als pharmazeutische Verbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1100800

Country of ref document: EP

REN Ceased due to non-payment of the annual fee